148 related articles for article (PubMed ID: 25010001)
1. The cost of genetic testing for ocular disease: who pays?
Capasso JE
Curr Opin Ophthalmol; 2014 Sep; 25(5):394-9. PubMed ID: 25010001
[TBL] [Abstract][Full Text] [Related]
2. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
3. Should patients with ocular genetic disorders have genetic testing?
Zanolli MT; Khetan V; Dotan G; Pizzi L; Levin AV
Curr Opin Ophthalmol; 2014 Sep; 25(5):359-65. PubMed ID: 24991870
[TBL] [Abstract][Full Text] [Related]
4. Genetic testing for inherited ocular disease: delivering on the promise at last?
Gillespie RL; Hall G; Black GC
Clin Exp Ophthalmol; 2014; 42(1):65-77. PubMed ID: 23845030
[TBL] [Abstract][Full Text] [Related]
5. Recommendations for genetic testing of inherited eye diseases: report of the American Academy of Ophthalmology task force on genetic testing.
Stone EM; Aldave AJ; Drack AV; Maccumber MW; Sheffield VC; Traboulsi E; Weleber RG
Ophthalmology; 2012 Nov; 119(11):2408-10. PubMed ID: 22944025
[TBL] [Abstract][Full Text] [Related]
6. Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations.
Lawrence WF; Peshkin BN; Liang W; Isaacs C; Lerman C; Mandelblatt JS
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):475-81. PubMed ID: 11352857
[TBL] [Abstract][Full Text] [Related]
7. Genetic testing for neurologic disorders.
Schneider SA; Schneider UH; Klein C
Semin Neurol; 2011 Nov; 31(5):542-52. PubMed ID: 22266891
[TBL] [Abstract][Full Text] [Related]
8. Genetic testing for breast and ovarian cancer: implications for life insurance.
Lemaire J; Subramanian K; Asch DA
LDI Issue Brief; 2000 Mar; 5(6):1-4. PubMed ID: 12523344
[TBL] [Abstract][Full Text] [Related]
9. Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population.
Peterson EA; Milliron KJ; Lewis KE; Goold SD; Merajver SD
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):79-87. PubMed ID: 11815404
[TBL] [Abstract][Full Text] [Related]
10. [Genetic testing and counselling in inherited eye disease].
Brøndum-Nielsen K; Jensen H; Timshel S; Grønskov K; Larsen M
Ugeskr Laeger; 2013 Sep; 175(36):2031-4. PubMed ID: 23992910
[TBL] [Abstract][Full Text] [Related]
11. Genetic testing for inherited eye disease: who benefits?
Wiggs JL; Pierce EA
JAMA Ophthalmol; 2013 Oct; 131(10):1265-6. PubMed ID: 23949187
[No Abstract] [Full Text] [Related]
12. [Health risks, heredity screening and insurance].
Arnold IJ; van de Vathorst S
Ned Tijdschr Geneeskd; 1991 Mar; 135(11):480-3. PubMed ID: 2023656
[No Abstract] [Full Text] [Related]
13. The impact of insurance coverage on the prenatal genetic counseling process: An exploration of genetic counselors' experiences with TRICARE.
Brown J; O'Neill S; DiNonno W; Hess O
Prenat Diagn; 2019 May; 39(6):448-455. PubMed ID: 30883831
[TBL] [Abstract][Full Text] [Related]
14. Risks and benefits of DNA testing for neurogenetic disorders.
Bird TD
Semin Neurol; 1999; 19(3):253-9. PubMed ID: 12194381
[TBL] [Abstract][Full Text] [Related]
15. Economic implications of insurance coverage for in vitro fertilization in the United States. A review.
Omurtag KR; Styer AK; Session D; Toth TL
J Reprod Med; 2009; 54(11-12):661-8. PubMed ID: 20120898
[TBL] [Abstract][Full Text] [Related]
16. Challenges in genetic testing for clinical trials of inherited and orphan retinal diseases.
Stone EM
Retina; 2005 Dec; 25(8 Suppl):S72-S73. PubMed ID: 16374347
[No Abstract] [Full Text] [Related]
17. Economic considerations for health insurance coverage of emerging genetic tests.
Giacomini M; Miller F; O'Brien BJ
Community Genet; 2003; 6(2):61-73. PubMed ID: 14560066
[TBL] [Abstract][Full Text] [Related]
18. Costs and benefits of improving access to psychotherapies for common mental disorders.
Dezetter A; Briffault X; Ben Lakhdar C; Kovess-Masfety V
J Ment Health Policy Econ; 2013 Dec; 16(4):161-77. PubMed ID: 24526585
[TBL] [Abstract][Full Text] [Related]
19. Disparities in BRCA testing: when insurance coverage is not a barrier.
Olaya W; Esquivel P; Wong JH; Morgan JW; Freeberg A; Roy-Chowdhury S; Lum SS
Am J Surg; 2009 Oct; 198(4):562-5. PubMed ID: 19800469
[TBL] [Abstract][Full Text] [Related]
20. The 3C study: coverage cost and care of type 1 diabetes in China--study design and implementation.
McGuire H; Kissimova-Skarbek K; Whiting D; Ji L
Diabetes Res Clin Pract; 2011 Nov; 94(2):307-10. PubMed ID: 22056720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
